Oncology Pharmacy Specialty Sessions

The Oncology Pharmacy Specialty Sessions are live educational programs that focus on new developments in oncology pharmacy. On an annual basis, BCOPs may earn at least 5.0 recertification hours for the live educational program following successful completion of a Web-based self-assessment examination. Actual hours available through live programming may vary from year to year, based on the content of the programming.

The Oncology Pharmacy Specialty Sessions are updated annually and are presented at the Annual Meetings of the Hematology/Oncology Pharmacy Association (HOPA), and repeated at the Annual Meeting of the American College of Clinical Pharmacy (ACCP), and at the Midyear Clinical Meeting of the American Society of Health-System Pharmacists (ASHP). BCOPs who wish to earn recertification credit for the Oncology Pharmacy Specialty Sessions must register and attend one of these meetings and attend the specialty sessions in full at the meeting in order to purchase access to the Web-based posttest. Upon successful completion of the post test, BCOPs will earn at least 5.0 hours of recertification credit. Partial credit is not available. The self-assessment examination must be submitted by December 31 of the year the sessions were attended.

2015 Oncology Pharmacy Specialty Session Availability

In 2015, the Oncology Pharmacy Specialty Sessions will be presented first during the 2015 HOPA Annual Meeting, March 25–28 in Austin, Texas. The Specialty Sessions will be repeated at the 2015 ACCP Global Conference on Clinical Pharmacy, October 17–21, in San Francisco, California and at the ASHP Midyear Clinical Meeting, December 6–10, in New Orleans, Louisiana. The content of the Specialty Sessions will be the same at each meeting. Visit the Web sites of the organizations for more information on the Specialty Sessions as information becomes available. HOPA: www.hoparx.org; ACCP: www.accp.com; ASHP:www.ashp.org.

© 2017 American College of Clinical Pharmacy and American Society of Health‑System Pharmacists